Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | PPARG | P37231 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | PPARA | Q07869 | 1/20 | 0.46 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | POLA1 | P09884 | 1/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.43 |
| ▸ | DGKA | P23743 | 1/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15627608 | 1.00 | MEN1 (0.50) | MEN1KMT2APPARGL3MBTL1PPARA | |
| SCHEMBL7191955 | 1.00 | MEN1 (0.50) | MEN1KMT2APPARGL3MBTL1PPARA | |
| SCHEMBL7193691 | 1.00 | MEN1 (0.50) | MEN1KMT2APPARGL3MBTL1PPARA | |
| SCHEMBL13276620 | 1.00 | MEN1 (0.50) | MEN1KMT2APPARGL3MBTL1PPARA | |
| SCHEMBL14734043 | 0.90 | LMNA (0.50) | PPARGL3MBTL1PPARAMAPTLMNA | |
| SCHEMBL14734044 | 0.90 | LMNA (0.50) | PPARGL3MBTL1PPARAMAPTLMNA | |
| SCHEMBL15166985 | 0.89 | LMNA (0.51) | MEN1KMT2APPARGL3MBTL1PPARA | |
| SCHEMBL15167138 | 0.89 | LMNA (0.51) | MEN1KMT2APPARGL3MBTL1PPARA | |
| SCHEMBL15167445 | 0.89 | LMNA (0.51) | MEN1KMT2APPARGL3MBTL1PPARA | |
| SCHEMBL15167267 | 0.89 | LMNA (0.51) | MEN1KMT2APPARGL3MBTL1PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9133305-B2 | Polyurethane synthesis by means of self-condensation | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2015-09-15 | — | — | US | disclosed |
| US-20120264901-A1 | POLYURETHANE SYNTHESIS BY MEANS OF SELF-CONDENSATION | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2012-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120264901-A1 | POLYURETHANE SYNTHESIS BY MEANS OF SELF-CONDENSATION | CCNA1, RER1, CBR1 | MEN1 862/4885KMT2A 1674/4885PPARG 4371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.